FDA Restricts Johnson & Johnson’s COVID-19 Vaccine Due to Blood Clot Risk
US regulators strictly limit who can receive Johnson & Johnson’s COVID vaccine over rare but serious blood clots risk.
- Read in
- বাংলা
US regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Check Tweet:
JUST IN - US regulators strictly limit who can receive Johnson & Johnson’s COVID vaccine over "rare but serious" blood clots risk.https://t.co/dCiPE4ndSk
— Disclose.tv (@disclosetv) May 5, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on May 06, 2022 04:16 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
